Wordt geladen...
CROI 2015: Highlights of Viral Hepatitis Therapy
High cure rates with all-oral regimens for patients with HIV/hepatitis C virus (HCV) coinfection were a highlight of the 2015 Conference on Retroviruses and Opportunistic Infections. Twelve weeks of sofosbuvir and daclatasvir led to sustained virologic response (SVR) rates of 96% in treatment-nave a...
Bewaard in:
| Gepubliceerd in: | Top Antivir Med |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
IAS-USA
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6148900/ https://ncbi.nlm.nih.gov/pubmed/25965313 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|